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Abstract
Background: Autosomal dominant polycystic kidney disease (ADPKD) is a common cause of inherited renal failure that
results from mutations in PKD1 and PKD2. The disorder is characterized by focal cyst formation that involves somatic
mutation of the wild type allele in a large fraction of cysts. Consistent with a two-hit mechanism, mice that are homozygous
for inactivating mutations of either Pkd1 or Pkd2 develop cystic kidneys, edema and hemorrhage and typically die in
midgestation. Cystic kidney disease is unlikely to be the cause of fetal loss since renal function is not required to complete
gestation. One hypothesis is that embryonic demise is due to leaky vessels or cardiac pathology.
Methodology/Principal Findings: In these studies we used a series of genetically modified Pkd1 and Pkd2 murine models to
investigate the cause of embryonic lethality in mutant embryos. Since placental defects are a frequent cause of fetal loss, we
conducted histopathologic analyses of placentas from Pkd1 null mice and detected abnormalities of the labyrinth layer
beginning at E12.5. We performed placental rescue experiments using tetraploid aggregation and conditional inactivation
of Pkd1 with the Meox2 Cre recombinase. We found that both strategies improved the viability of Pkd1 null embryos.
Selective inactivation of Pkd1 and Pkd2 in endothelial cells resulted in polyhydramnios and abnormalities similar to those
observed in Pkd1
2/2 placentas. However, endothelial cell specific deletion of Pkd1 or Pkd2 did not yield the dramatic
vascular phenotypes observed in null animals.
Conclusions/Significance: Placental abnormalities contribute to the fetal demise of Pkd
2/2 embryos. Endothelial cell
specific deletion of Pkd1 or Pkd2 recapitulates a subset of findings seen in Pkd null animals. Our studies reveal a complex
role for polycystins in maintaining vascular integrity.
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Introduction
Autosomal dominant polycystic kidney disease (ADPKD) is a
common cause of inherited renal failure [1]. Affected individuals
develop progressive renal cyst formation and enlargement that
ultimately destroys normal kidney architecture. Mutations in
PKD1 are responsible for 85% of all cases while mutations in PKD2
account for the remainder [2]. Both forms of the disease are
associated with a similar array of extra renal manifestations,
including liver cysts and cardiovascular complications such as
intracranial aneurysms and mitral valve prolapse [3].
The protein products of PKD1 (Polcystin-1, PC1) and PKD2
(Polycystin-2, PC2) are thought to function in a common signaling
pathway that has yet to be completely elucidated [4,5]. PC1 is
predicted to be a large, non-kinase membrane receptor with a
multi-component extracellular N-terminus, 11 transmembrane
domains and an intracellular C-terminus that is critical for signal
transduction. PC2 is a Ca
2+-permeable, TRP-like channel that
interacts with the C-terminus of PC-1 forming a receptor channel
complex that has been hypothesized to mediate mechanosensory
signal transduction by primary cilia in several cell types including
renal epithelial cells and endothelial cells [6,7,8].
Although both PC1 and PC2 are expressed in nearly every
tissue that has been studied, the manifestations of gene loss in
humans are relatively restricted and focal in nature. For example,
in the kidney, microdissection studies of early stage human PKD
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affects only a subset of cells in the renal tubules [9]. A two hit
model of disease is consistent with this observation and is
supported by genetic analyses of cystic tissues where somatic
mutations affecting the wild type allele can be detected in a large
fraction of cysts [10,11].
Studies of mice with targeted mutations of Pkd1 and Pkd2 are in
keeping with this model [10,12,13]. Pkd1 and Pkd2 heterozygous
mice present with few if any renal cysts but develop dramatic cystic
disease when the other allele undergoes somatic deletion at a high
rate [14,15,16,17]. In addition, germline homozygous mutants
develop severely cystic kidneys and die in utero at mid-gestation
[14,15,16,18,19,20,21,22,23]. Polyhydramnios, severe edema and
hemorrhage are universal findings in homozygous mutants of
either locus by E12.5.
Taken together, the data from mouse models suggests that
ADPKD is recessive at the molecular level and that embryonic loss
of either Pkd1 or Pkd2 is incompatible with viability. Interestingly
despite the high incidence of PKD mutations, there have been no
reports of live-born humans with inactivating, biallelic PKD1 or
PKD2 mutations. In the only example reported in the literature, a
marriage between affected first-degree cousins with PKD1-linked
disease resulted in a higher than expected rate of fetal loss [24].
The authors concluded that biallelic mutation of PKD1 was the
likely cause of embryonic lethality.
Why does polycystin loss result in fetal death? It is unlikely that
cystic renal disease is the cause of intrauterine demise since renal
function is not required to complete gestation. The uniform
presence of vascular fragility and edema in Pkd null mice along
with reports of cardiac defects in some models has led to the
hypothesis that the demise of these embryos is primarily
cardiovascular, due to a combination of leaky vasculature and
possibly cardiac defects [18,20,21,22,23,25]. This is in keeping
with the expression of polycystins throughout the embryonic and
adult cardiovascular systems as well as in both endothelial cells and
vascular smooth muscle cells [7,8,18,26].
In this study we address the cause of lethality in Pkd null
embryos. We show that polycystins are expressed in the murine
placenta and that placental abnormalities are a likely cause of fetal
demise in polycystin null animals. We also used floxed alleles of
Pkd1 and Pkd2 to investigate the roles of polycystins in various
placental cells types. Tetraploid aggregation as well as conditional
knock out experiments with both Meox2 and Tie2-Cre recombi-
nases suggest that Pkd1 and Pkd2 play a functional role in both
trophoblast and endothelial cell compartments of the placenta.
Surprisingly, endothelial loss of Pkd1 or Pkd2 induced by a Tie2-
Cre recombinase does not recapitulate the vascular collapse
observed in null animals.
Results
Pkd1 and Pkd2 are expressed in Murine Placenta
We used RT-PCR to document the expression of Pkd1 and Pkd2
in murine placentas between E10.5 and E14.5 (Figure 1A).
Placental expression of PC1 and PC2 could also be detected by
Western analysis by E12.5 (Figure 1 B and C).
Characterization of Pkd1
2/2 Null Placentas
Defects in the structure and/or function of the chorioallantoic
placenta are recognized to be common causes of mid-to late
gestational loss of pregnancy. Since Pkd1 and Pkd2 were expressed
in placental tissue we considered the possibility that placental
failure might be the cause of fetal demise in Pkd null embryos
[27,28]. We systematically examined the placentas of Pkd1
+/+,
Pkd1
+/2 and Pkd1
2/2 mice at gestational ages E10.5 through
E15.5 in both mixed (129Sv/BL/6) and congenic C57BL/6
backgrounds. At E10.5–E11.5, the deciduas basalis and spongio-
trophoblast layers of all three genotypes were similar though the
labyrinth layer of Pkd1
2/2 placentas appeared slightly less
developed with polyhydramnios apparent as early as E11.5
(Figure 1 D and E). At later time points, the polyhydramnios
became more severe and abnormalities in Pkd1
2/2 placentas
became progressively more noticeable. In Figure 2 null placentas
harvested from C57BL/6 congenic E12.5 embryos were stained
for isolectin B4 (IB4), a marker that highlights the extracellular
matrix surrounding fetal blood vessels [29]. We observed
disorganized fetal arteriole and capillary networks and Pkd1
2/2
placentas exhibited a statistically significant decrease in the
number of vascular branches when compared with wild type
controls (Figure 2 A, C, D and E). The trophoblast lined maternal
vascular channels also appeared dilated (Figure 2A, arrows in
Figure 2 C and D). Small areas of separation, hemorrhage and
necrosis with fibrin deposition were occasionally observed at the
maternal-fetal interface. In addition, antibodies to alpha smooth
actin (a-SMA) detected fewer pericytes, possibly reflecting a
decrease in the number of fetal vessels (Figure 2B). Despite a
decrease in vascular complexity (Figure 2E), at E12.5, there was no
significant difference in either the total placental area (Pkd1
2/2:
5.5760.42 mm
2 vs. Pkd1
+/+: 6.2260.27 mm
2, P=.24) or in the
labyrinth area between Pkd1
2/2 and controls. (Pkd1
2/2: 2.856.27
vs. Pkd1
+/+: 3.46.24, P=.16).
There was variability in the onset of severe placental defects,
with congenic C57BL/6 Pkd1
2/2 mice generally exhibiting more
severe abnormalities at earlier time points compared with the
mixed background. This is consistent with the observation that
congenic C57BL/6 Pkd1
2/2 embryos also die at earlier time
points. Pkd2 null placentas exhibit similar histologic abnormalities
[30].
Placental Rescue Experiments
In order to explore whether a placental defect might be
responsible for intrauterine demise, we performed placental rescue
experiments using two strategies. First, we aggregated wild type
tetraploid embryos with diploid embryos derived from Pkd1
+/2
intercrosses [31]. In this method, tetraploid, wild type cells
contribute preferentially to extraembryonic placental tissues
including trophoblasts while the embryo is derived exclusively
from potentially mutant diploid cells. Our results were consistent
with a partial rescue of lethality since 3/7 embryos harvested at
E17.5 were viable Pkd1
2/2, which is remarkable since Pkd1 null
embryos rarely survive past E15.5 (Table S1). Of the remaining
embryos, three were Pkd1
+/2 and one was Pkd1
+/+. Consistent
with the enhanced viability of the ‘‘rescued’’ Pkd1
2/2 null
embryos, we observed variable improvement in the placental
histology (Figure 3 C and D). As expected Pkd1
2/2 fetuses had
severe cystic kidney disease, edema and polyhydramnios due to the
lack of fetal incorporation of tetraploid cells (Figure 3 A and B).
As a second complementary approach, we crossed a floxed
allele of Pkd1 (Pkd1
cond/cond)t oPkd1
+/2, Meox2-Cre
+ mice to produce
embryos in which the floxed Pkd1 allele was inactivated in the E6.5
embryo but not in the placental trophoblasts or extra-embryonic
endoderm lineages [15,32]. Pkd1
cond/2, Meox2-Cre
+ mice also
exhibited cystic kidneys, edema, and polyhydramnios (Figure 4A)
but a substantial fraction survived to birth (,16/102, expected
,25/102). Those that survived died shortly after birth of apparent
respiratory failure. The hearts of edematous Pkd1
cond/2, Meox2-Cre
+
pups appeared normal with intact valves and septa, making this
organ an unlikely cause of either their edema or death.
Pkd1 and Pkd2 in Placenta
PLoS ONE | www.plosone.org 2 September 2010 | Volume 5 | Issue 9 | e12821Examination of Pkd1
cond/2, Meox2-Cre
+ placentas likewise
showed a variable degree of improvement in placental architec-
ture, suggesting a partial rescue. In Figure 4B and C (middle
panels), the Pkd1
cond/2, Meox2-Cre
+ placenta was similar to wild
type, with respect to the density and complexity of placental
vessels. In contrast, another placenta of the same genotype
exhibited fewer fetal vessels and more dilated vascular spaces
(Figure 4B and C, right panels). This was consistent with the
observation that only a subset of Pkd1
cond/2, Meox2-Cre
+ embryos
survived to birth. On average, however, Pkd1
cond/2, Meox2-Cre
+
placentas had a lower density of fetal vessels compared with
controls (Figure 4E) but there was no difference in the size of any
placental layer. In order to confirm the pattern of Meox2-Cre
activity in the fetal placenta, we carried out crosses using mice
carrying the ROSA26R reporter transgene [33]. The Meox2-Cre
recombinase activity was restricted to the fetal portion of the
placenta, overlapping with the vasculature as marked by PECAM
1 expression (Figure 4D). There was no obvious difference in Cre
recombinase activity between various placentas and Pkd1
+/cond,
Meox2-Cre
2;Rosa26R did not stain with b-galactosidase.
Endothelial cell Deletion of Pkd1 or Pkd2 Results in
Reduced Viability and Placental Defects
These findings raised the possibility that the abnormalities
detected in Pkd1 and Pkd2 null placentas might be due to a
requirement for these genes not only in trophoblasts but also in the
vascular compartment of the labyrinth layer. In order to examine
this possibility we ablated Pkd1 in fetal endothelial cells using a
Tie2-Cre transgene [34]. When we crossed Pkd1
cond/cond and
Pkd1
+/2, Tie2-Cre
+ mice we found a reduction in live born
Pkd1
cond/2; Tie2-Cre
+ animals (referred to as Pkd1
endo2), indicating
that endothelial cell loss of polycystin-1 results in the embryonic
demise of a significant fraction of animals (Table 1). If pregnancies
were harvested before E18.5, however, mendelian ratios were
restored.
We generated a novel conditional allele of Pkd2 in order to carry
out analogous experiments (Figure S1 and S2, Table S2).
Endothelial cell specific deletion of Pkd2 (Pkd2
endo2) similarly
resulted in embryonic demise (Table 2). We note that in matings of
Pkd2
cond/cond and Pkd2
cond/+; Tie2-Cre
+ mice, we consistently
observed a lower than expected fraction of Pkd2
cond/+ progeny.
Figure 1. Coordinate Expression of PC1 and PC2 in Murine Placentas. A. Expression of Pkd1 and Pkd2 in E10.5–E14.5 placentas assayed by
quantitative RT-PCR, normalized to RPL13. N=4 placentas were analyzed at E10.5 and E14.5 and N=3 placentas at the other time points. B.
Immunoprecipitation of PC1 from placentas harvested at E12.5 and E14.5 and E12.5 embryos using a chicken antibody directed at the PC1 C-
terminus. PC1 was detected on Western by rabbit antisera also directed at the PC1 C-terminus. Full length PC1 (FL) and the PC1 C-terminal cleavage
fragment (CTF) are absent in the Pkd1
2/2 embryo. The asterisk denotes a non-specific band previously described [46]. Pkd1
2/2 placentas were not
used as a negative control since they would be expected to contain maternal PC1. C. Expression of PC2 by Western analysis in E10.5–E14.5 placentas.
Expression level was normalized to actin. N=4 placentas analyzed at each time point. Inset shows a representative Western blot. D. Representative
Pkd1
2/2 and littermate control (Pkd1
+/+) embryos harvested at E11.5. Asterisk indicates polyhydramnios. E. Quantification of amniotic fluid. Increased
amniotic fluid can be detected in Pkd1
2/2 embryos as early as E11.5. ** p,.01, *** p,.001.
doi:10.1371/journal.pone.0012821.g001
Pkd1 and Pkd2 in Placenta
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2/2 placentas. A. Low power (upper panels) and high power (lower panels) views of congenic
C57BL/6, E12.5 placentas stained with haematoxylin-eosin (H&E). B. Pericytes in E12.5 placentas stained with antibodies to alpha smooth actin (a-
SMA). The density of pericytes in Pkd1
2/2 placentas is reduced, consistent with a decrease in the density of fetal vessels. C. Low power (upper panels)
and high power (lower panels) views of E12.5 placentas stained with isolectin B4 (IB4), highlighting the matrix surrounding fetal vessels. Arrowheads
denote fetal vessels. Arrows indicate maternal vascular spaces. The null placenta has fewer fetal vessels and dilated maternal spaces. D. Fetal vessels
in Pkd1
+/+ and Pkd1
2/2 12.5 dpc placenta stained with fluorescent-labeled isolectin B4 (green) and laminin (red). Nuclei stained with DAPI are blue.
White arrowheads indicate fetal vessels that are outlined by IB4 and laminin. Arrows indicate maternal vascular spaces. There is a decrease in the
number of fetal vessels. E. Vessel density is decreased in the labyrinth layer of Pkd1
2/2 placentas compared with Pkd1
+/+ controls (37.661.1 branches/
mm
2 vs. 46.362.3 respectively) * p,.05.
doi:10.1371/journal.pone.0012821.g002
Figure 3. Placental Rescue by Tetraploid Aggregation. A, B. Haematoxylin-eosin stained sections of E17.5 tetraploid rescue n4/Pkd1
2/2
embryos show classic Pkd1 null phenotype with renal cysts (Panel A) and pancreatic cysts (Panel B). This is because tetraploid wild type cells are not
incorporated into the fetus. ‘‘Cy’’ denotes cysts. C. Haematoxylin-eosin stained placental sections harvested from viable E17.5 wild type (Pkd1
+/+)o r
Pkd1 mutant (n4/Pkd1
2/2) embryos. The defect in the labyrinth layer appears improved in this placenta. D. IB4 staining of representative sections
from E17.5 Pkd1
+/+ (left panels) and n4/Pkd1
2/2 placentas (right panels). There was variable improvement in the placental phenotype with the n4/
Pkd1
2/2 placenta in the upper panel appearing to be more like the wild type placenta.
doi:10.1371/journal.pone.0012821.g003
Pkd1 and Pkd2 in Placenta
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cond/+ and Pkd2
cond/cond mice are phenotypically normal
and born at the expected frequencies (Table S2), the most likely
explanation is that the Pkd2 locus and the Tie2-Cre transgene are
genetically linked but far enough apart for some recombination to
occur. We detected a further reduction in live born Pkd2
cond/cond;
Tie2-Cre
+ (Pkd2
endo2) vs. Pkd2
cond/+ progeny (P=.01, chi-square test)
that was not present when pregnancies were harvested before
E15.5. These findings suggest that there is fetal lethality of
Pkd2
endo2 embryos superimposed on segregation distortion.
We examined Pkd1
endo2 and Pkd2
endo2 placentas along with
littermate controls and found a phenotype similar to that des-
cribed for Pkd1 and Pkd2 null animals (Figure 5). Isolectin B4 and
laminin staining served to highlight a significant decrease in the
density of fetal vessels with a simplified vascular branching
pattern and dilated maternal spaces. In addition, staining for
alpha-smooth muscle actin appeared more sparse and disorga-
nized when compared with control placentas. There was no
significant difference in the size of placental layers (labyrinth or
spongiotrophoblast) between Pkd1
endo2 or Pkd2
endo2 placentas
versus controls.
Phenotype of mice lacking endothelial cell Polycystins
Unexpectedly, the phenotypic consequences of endothelial cell
loss of either Pkd1 or Pkd2 appeared to be primarily restricted to
extra-fetal tissues. Pkd1
endo2 and Pkd2
endo2 embryos universally
developed polyhydramnios (Figure 6, Figure S2) and could be
easily distinguished from wild type littermates. Only a small
fraction of mutant animals, however, exhibited hemorrhages
(Figure 6 E and F). In striking contrast to the Pkd1 and Pkd2 null
mice, which universally had edema, none of the Pkd1
endo2 or
Pkd2
endo2 embryos were edematous (Figure 5A, Figure S2F). We
also failed to find any obvious cardiac or renal abnormalities in
several Pkd1
endo2 and Pkd2
endo2 embryos that were sectioned
(Figure 6D, Figure S2G). We maintained a cohort of the Pkd1
endo2
mice (n=15) for up to one year and observed no differences in the
rate of sudden death. Autopsies performed on a subset of the
Figure 4. Conditional Inactivation of Pkd1 using Meox2 Cre recombinase. A. Conditional inactivation of Pkd1 using a Meox-2 Cre
recombinase expressing mouse line results in the typical polycystin null phenotype, reflecting high activity of the recombinase in the embryo.
The top panel shows the gross appearance of Pkd1
2/cond; Meox2-Cre
+ (Pkd1
Meox2-Cre) and Pkd1
+/cond; Meox2-Cre
2 (Pkd1
+/+) neonates (top panel).
Pkd1
Meox2-Cre mutants are severely edematous (*). The bottom panels show haematoxylin-eosin stained sections of cystic kidney (left) and cystic
pancreas (right). ‘‘Cy’’ denotes cysts. B, C. Sections of E14.5 placentas from Pkd1
cond/+, Meox2-Cre
2 (Pkd1
+/+)o rPkd1
cond/2, Meox2-Cre
+(Pkd1
Meox2-Cre)
embryos stained with haematoxylin-eosin (B) or IB4 (C). Two representative examples of Pkd1
Meox2-Cre placentas show different degrees of rescue
when compared with a Pkd1
+/+ littermate control. The Meox-2Cre recombinase activity would be expected to spare placental trophoblasts and cells
derived from extra-embryonic endoderm lineages. D. In order to determine the spatial pattern of placental Meox-2 Cre activity, frozen sections of
Pkd1
cond/2; Meox2-Cre
+, Rosa26R E14.5 placentas were stained with b-galactosidase (left panel) or antibodies to Pecam-1 (right panel). The dotted
white line outlines the stained area. Nuclei are stained with DAPI (blue). Cre activity appears to overlap with anti-Pecam 1 staining, suggesting activity
in fetal vessels that comprise the placental labyrinth layer. E. Vessel density is decreased in the labyrinth layer of Pkd1
Meox2-Cre placentas compared
with Pkd1
+/+ controls (3762.6 branches/mm
2 vs. 47.662.3 respectively) ** p,.01.
doi:10.1371/journal.pone.0012821.g004
Pkd1 and Pkd2 in Placenta
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or intracranial aneurysms.
Efficiency of Tie2-Cre Recombinase
Although 100% of Pkd1
endo2 and Pkd2
endo2 embryos exhibited
polyhydramnios and placental abnormalities in utero, there was
variability in the severity of the phenotype with almost 2/3 of
Pkd1
endo2 mutants surviving to birth. One explanation for these
observations could be the presence of unidentified genetic
modifiers operating in the mixed background used for these
studies. Alternatively phenotypic variability could be due to
differences in the degree of Cre recombinase activity. In order to
test for the efficiency of Tie2-Cre mediated recombination in
endothelial cells we bred Pkd2
cond/+, Tie2-Cre
+ mice with a murine
line carrying the Z/AP transgene [35]. Tissues harvested from
Pkd2
cond mice carrying both Tie2-Cre and Z/AP transgenes (N=3)
demonstrated alkaline phosphatase staining in endothelial cells of
all vessels examined (Figure 7A–D). Specifically the intimal layer
of the aorta demonstrates intense alkaline phosphatase activity, as
do most fetal vessels in the labyrinth layer of the placenta and the
small vessels of the kidney and brain. As a complementary
approach, we isolated endothelial cells from Pkd1
endo2 (n=5) and
Pkd2
endo2 (n=4) embryos as well as controls and assayed for
deletion using either a PCR based strategy or Western analysis
(Figure 7E, F, G, H). We found that both Pkd1 and Pkd2 levels
were reduced by .70%.
Discussion
In this report we demonstrate that polycystins play a role in
placental development. Pkd1 null placentas have a reproducible
defect in the labyrinth layer that is characterized by diminished
complexity of fetal vascular networks along with dilated fetal and
maternal spaces. We used two independent strategies to rescue
Pkd1 function in extra-embryonic placental tissue and both
resulted in improved viability of Pkd1
2/2 embryos. We also found
that targeted deletion of either Pkd1 or Pkd2 in endothelial cells led
to a similar placental abnormality along with reduced embryonic
viability. We conclude from these experiments that a defect in
placentation is a likely cause of fetal demise in Pkd1 and Pkd2 null
mice and that polycystins are required in both the trophoblast and
the fetal vascular compartment of the placenta. These data are
consistent with the absence of live-born humans with biallelic
inactivating mutations of PKD1 or PKD2.
In the mouse, the placental labyrinth layer is the main site of
contact between the fetal and maternal circulation. The labyrinth
consists of a highly branched fetal vascular network in close
apposition to trophoblast lined maternal sinusoids [36]. As in the
developing kidney, the formation of the placental labyrinth layer
involves complex reciprocal interactions between trophoblasts and
incipient vessels [37]. The reduced complexity of the labyrinth
layer in Pkd mutants, suggests an additional function for the
PC1/PC2 receptor-channel complex in regulating placental
morphogenesis.
Interestingly, the phenotype that we observed in Pkd mutant
placentas is similar to the defect described for PDGFB (platelet
derived growth factor b) or PDGFRb (PDGF receptor b) null
placentas [29]. Placentas from these animals exhibited dilated
embryonic blood vessels with fewer pericytes and trophoblasts but
no reduction in size of either the labyrinth or spongiotrophoblast
layers. These abnormalities are attributed to a failure of pericyte
recruitment to fetal vessels, which in turn is presumed to affect the
morphogenesis of complex vascular networks that comprise the
placental labyrinth layer. Whether loss of either Pkd1 or Pkd2 in
the fetal placenta affects PDGF signaling will require further
investigation.
One ubiquitous feature of all Pkd1 and Pkd2 targeted alleles
is the presence of dramatic polyhydramnios in null embryos.
Table 1. Deletion of Pkd1 in endothelial cells.
Pkd1
cond/cond vs. Pkd1
+/2; Tie2-Cre
+
Offspring genotype Expected ratio
Obtained Ratio
(Perinatal Period)
Obtained Ratio
(13.5–18.5 d.p.c)
Pkd1cond/2; Tie2-Cre+ (Pkd1endo2) 25% 16.9% (n=47) 23.3% (n=45)
Pkd1cond/2 25% 27.3% (n=76) 23.8% (n=46)
Pkd1cond/+; Tie2-Cre+ 25% 26.2% (n=73) 24.4% (n=47)
Pkd1cond/+ 25% 29.5% (n=82) 28.5% (n=55)
doi:10.1371/journal.pone.0012821.t001
Table 2. Deletion of Pkd2 in endothelial cells.
Pkd2
cond/cond vs. Pkd2
cond/+; Tie2-Cre
+
Offspring genotype Expected ratio
Obtained Ratio
(Perinatal Period)
Obtained Ratio
(8.5–15.5 d.p.c)
Pkd2cond/cond; Tie2-Cre+(Pkd2endo2) 25% 4.3% (n=4) 19.2% (n=14)
Pkd2cond/cond 25% 35.5% (n=33) 41.1% (n=30)
Pkd2cond/+; Tie2-Cre+ 25% 44.1% (n=41) 28.7% (n=21)
*Pkd2cond/+ 25% 16.1% (n=15) 11% (n=8)
*The lower than expected percentage of Pkd2
cond/+ progeny suggests that Pkd2 and the Tie2-Cre transgene are linked but far enough apart for some recombination to
occur. There are fewer Pkd2
cond/cond; Tie2-Cre
+ (Pkd2
endo2) progeny compared with Pkd2
cond/+ (P=.01, chi-square test).
doi:10.1371/journal.pone.0012821.t002
Pkd1 and Pkd2 in Placenta
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alone was sufficient to recapitulate this phenotype. We were
unable to identify additional renal, pulmonary or cardiac
pathology that might explain these findings. Since placental
membranes are thought to play a role in amniotic fluid dynamics,
one possibility is that the polyhydramnios in these embryos is
related to the placental abnormalities described above [38].
We note that our findings differ from those recently published
using another targeted Pkd1 null allele [39]. These authors were
unable to detect a placental defect and concluded that polyhy-
dramnios, which precedes cyst formation, is caused by abnormal
proximal tubular function and excessive loss of renal solutes.
Our data, however, are not consistent with this conclusion since
we see polyhydramnios as early as E11.5, prior to filtration by
the metanephric kidney [40]. In addition, Pkd
endo2 embryos lack
a demonstrable renal phenotype yet they have significant
polyhydramnios, making it unlikely that this is renal in origin.
Finally although these authors reported that gross morphometry
was no different in Pkd1 null placentas, more sensitive measures
confirm a reproducible defect in the complexity and density of
fetal vessels in the placental labyrinth.
One surprising aspect of our work is the relatively limited
impact of selective endothelial inactivation of either polycystin in
the intact animal. Both Pkd1 and Pkd2 are expressed through out
the cardiovascular system and null animals have a dramatic
vascular phenotype manifest by edema and vascular hemorrhage
[18,20,25]. Moreover these proteins have been detected in the
primary cilia of cultured endothelial cells where they are reported
to be involved in sheer stress sensing thereby activating a variety of
signaling pathways that result in nitric oxide production [7,8]. Yet,
selective inactivation of either Pkd1 or Pkd2 in endothelial cells
using a Tie-2 Cre recombinase is not sufficient to reproduce all
Figure 5. Deletion of Pkd1 or Pkd2 in endothelial cells results in abnormal placental histology. A, B. Representative E14.5 Pkd2
endo2 and
littermate control (Pkd2
endo+) placental sections stained with PAS. Area within the square of Panel A is located in the labyrinth layer (lt), and is shown
at larger magnification in Panel B. ‘‘st’’=spongiotrophoblast. Arrow indicates a dilated vascular space that is likely maternal. C, D. Representative
sections of E18.5 Pkd1
endo2 (Panel C, right), E14.5 Pkd2
endo2 (Panel D, right) and littermate control placentas (Pkd1
endo+ and Pkd2
endo+ left panels, C
and D, respectively) stained as indicated. Both Pkd1
endo2 and Pkd2
endo2 placentas have fewer fetal vessels and investing pericytes when compared
with controls. Arrowheads and arrows denote fetal vessels and maternal vascular spaces, respectively. E. Quantification of vessel density in the
placental labyrinth. For Pkd1
endo2 vs. Pkd1
endo+, the number of vessel branches is 45.362 and 57.962.9, respectively. For Pkd2
endo2 vs. Pkd2
endo+ the
number of branches is 47.560.7 and 54.561.1. P **p,.01.
doi:10.1371/journal.pone.0012821.g005
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endo2 animals lack
edema, which has been presumed to be due to leaky junctions
between endothelial cells [20].
There are several conceivable explanations for these contradic-
tory observations. It is possible, for example, that endothelial cells
which escape Cre-mediated Pkd gene inactivation have sufficient
activity to avert a more dramatic vascular phenotype. This seems
unlikely given the high degree of Cre recombinase activity that we
observed in all tissues examined as well as the greatly reduced level
of polycystin expression that was present in endothelial cells
isolated from Tie2-Cre
+ specimens. In addition we note that others
have used this Tie2-Cre recombinase line to demonstrate essential
endothelial cell functions of other genes [41,42,43]. Alternatively,
it is theoretically possible that the edematous phenotype is caused
by the loss of polycystin in the lymphatic system. However,
investigators have also used this Tie2-Cre recombinase to
specifically delete genes required for lymphatic development
[44]. We cannot exclude a primary cardiac cause for the fetal
edema and hemorrhages or a circulating factor released by a cell
other than one of endothelial origin. The apparent lack of
significant cardiac abnormalities in severely edematous embryos,
however, would make the former less likely.
One final possible explanation for our results arises from the
observation that polycystins are likely involved in heterologous
cell-cell interactions. The complete vascular phenotype ob-
served in null embryos may result only when Pkd genes are
simultaneously inactivated in multiple cell/tissue types. Alter-
natively, loss of polycystin in a functionally interacting cell type
like smooth muscle cells may have a different effect on
endothelial cell function than loss in endothelial cells them-
selves. Further studies using other Cre recombinases alone and
in combination will be necessary to address these possibilities.
While the present studies have not yet fully explained the
observed vascular phenotype, they do reveal the unexpectedly
complex role these proteins likely play in maintaining vascular
integrity.
Figure 6. Phenotypes Associated with Endothelial cell loss of Polycystin 1 or 2. A. Gross appearance of E14.5 Pkd1
endo2 (right) and
littermate control (left). The Tie2-Cre
+ (Pkd1
endo2) embryo has polyhydramnios indicated by the asterisk. In the lower panel the yolk sac was removed
and neither embryo has edema. B, C. Quantification of Amniotic Fluid demonstrates that both Pkd1
endo2 (B) and Pkd2
endo2 (C) embryos have
significant polyhydramnios, *p,.05; *** p,.001. D. Haematoxylin-eosin staining of kidney and heart from an E16.5 Pkd1
endo2 embryo and control.
There are no obvious abnormalities in the Pkd1
endo2 embryos. E. Gross appearance of an E14.5 Pkd2
endo2 embryo with multiple areas of hemorrhage
(right). A littermate control is also shown (left). Arrowheads indicate areas of hemorrhage. F. Haematoxylin-eosin staining of hemorrhagic areas in the
head (upper panel) and back (lower panel). High power view of areas in dotted square shown at right. Arrowheads indicate free red blood cells.
doi:10.1371/journal.pone.0012821.g006
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Ethics Statement
All studies were performed using protocols approved by the
University Animal Care and Use Committee (Protocol
MO05M318), and mice were housed and cared in pathogen-free
facilities accredited by the American Association for the
Accreditation of Laboratory Animal Care and meet federal
(NIH) guidelines for the humane and appropriate care of
laboratory animal.
Endothelial Cell Ablation of Pkd1 or Pkd2
Pkd1 null alleles and conditional alleles have been previously
described [15,45]. We inactivated Pkd1 or Pkd2 in endothelial cells
using transgenic mice expressing Cre recombinase under the
control of the Tie2 promoter (Tie2-Cre line; Masashi Yanagisawa,
UT Southwestern) [34]. Pkd1
+/2 heterozygotes were crossed to
Tie2-Cre transgenic mice to generate Pkd1
+/2, Tie2-Cre
+ males.
These males were crossed to Pkd1
cond/cond females to generate
Pkd1
cond/2, Tie2-Cre
+ mice (Pkd1
endo2) mice. For Pkd2, we mated
Pkd2
cond/cond homozygous females to the Pkd2
cond/+, Tie2-Cre
+ males
to create Pkd2
cond/cond, Tie2-Cre
+ mice (Pkd2
endo2). Genotyping was
performed from tail DNA using the REDExtract-N-Amp tissue
PCR Kit (SIGMA) according to the manufacturer’s protocol.
Pkd1
cond and null alleles were genotyped as previously described
[15]. Pkd2 alleles were genotyped as described in supplementary
methods S1.
Quantitative PCR Analysis
Total RNA was isolated from individual placentas using the
Qiagen RNA extraction kit. Five micrograms of total RNA was used
for first strand cDNA synthesis using Superscript II (Invitrogen).
Quantitative PCR(Stratagene Mx3005SP)f o rPkd1and Pkd2expression
was performed using the SYBR green PCR master mix (Applied
Biosystems). Samples were run in triplicate and an RT negative
sample was used to control for DNA contamination. A water control
was also included. Annealing temperatures and primer sequences are
as follows: Pkd1,6 0 uC: 59- TCTGGATGGGCTTCAGCAA and 59-
AGCGGGAAGGCAGTGGAT; Pkd2, 60uC: 59- AGACTTCTC-
GGTGTATAACGCAAA and 59- CACCCGTTGCTGGGAACT.
Values were normalized to those of RPL13 (ribosomal protein L13).
Immunoprecipitation/Western Blotting
Samples were homogenized in lysis buffer (20 mM Na
phosphate (pH 7.2), 150 mM NaCl, 1 mm EDTA, 10% glycerol,
1% Triton X-100 and protease inhibitor cocktail (Roche). The
homogenate was incubated for 1 hour on ice and cleared of debris
by centrifugation at 17, 0006g for 10 min at 4uC. Six milligrams
of protein in 1 ml was used for immunoprecipitation (IP) with 1 ul
of a polyclonal chicken antibody (chicken anti-CC) directed at the
mouse PC1 C-terminus. Western blots were probed with rabbit
antisera directed against the PC2 C-terminus (PC2 anti-CT,
1:1000) or the PC1 C-terminus (PC1 anti-CC, 1:1000). Antisera to
PC1 and PC2 have been described [46,47].
Figure 7. Tie2-Cre Recombinase is efficient in vivo. A–D. Alkaline Phosphatase staining of placenta (panels A, B), aorta (panel C) and kidney
(panel D) from 15.5 dpc Pkd2
cond, Tie2-Cre
+; Z/AP
+, mice. E, F. Endothelial cell DNA was prepared from N=5 E13.5 Pkd1
endo2 embryos (lanes 7–11). A 3-
primer PCR amplifies an 180 bp Pkd1 wild type band (lanes 1, 12), a 250 bp deleted (null) band (lane 6) and both bands equally in Pkd1
+/2 DNA
samples (lanes 2–5). The percent deletion of Pkd1 was quantified in Panel F (see methods). G. Representative Western blot prepared from 13.5 dpc
embryonic endothelial cells. The blot was probed with a C-terminal antibody to PC-2. Actin was used as a loading control. H. The relative expression
of PC-2 was determined by correcting for loading and then normalizing to Pkd2
endo+. N=4 for Pkd2
endo+ and Pkd2
endo2; N=3 for Pkd2
endo+/2.
doi:10.1371/journal.pone.0012821.g007
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Cre mediated recombination was visualized with either the
ROSA26R reporter line, which expresses lacZ upon Cre mediated
activation or the Z/AP double reporter line [33,35]. Frozen
sections were prepared for LacZ and alkaline phosphatase staining
using the method of Lobe et al. [35].
Immunohistochemistry
Placental sections were prepared and stained with peroxidase
conjugated IB4 (Sigma L5391) using published methods [29].
Placental pericytes were stained with the a-smooth muscle actin
immunohistology kit (IMMH2, from Sigma) using the manufac-
turer’s protocol. Anti-Laminin antibodies (Sigma L9393) were
used at a final concentration of 1:400. Frozen placental sections
were stained with Anti-Pecam antibody (BD Pharmingen,
MEC13.3) diluted to 1:500. Indirect fluorescence microscopy
was performed using a Nikon Eclipse E600 and images were
captured using a SPOT-RT monochromic camera (SPOT
Diagnostic Instruments). At least 4 sections were examined for
each genotype except in the case of tetraploid rescue.
Placental Morphometry
At least 4 independent pairs of placentas were used for
comparison: 1) Pkd1
2/2 vs. Pkd1
+/+ at E12.5 2) Pkd1
endo2 vs.
Pkd1
endo+atE18.5 3) Pkd2
endo2 vs. Pkd2
endo+atE14.5and 4)Pkd1
cond/2,
Meox2-Cre
+ vs. Pkd1
cond/2,M e o x 2 - C r e
2 at E14.5. Placentas werefixed,
paraffin embedded, hemisected and 5 mm sections were prepared.
Two separate placental sections representing the middle section of
the placenta were hybridized with a Tpbp riboprobe (Dr. JC Cross,
University of Calgary) to distinguish the spongiotrophoblast and the
overlying the labyrinth region.Digitalphotographs at1X were taken
and NIH Image J software was used to measure total placental area,
labyrinth and spongiotrophoblast areas. Three independent mea-
surements were taken for each layer and section. In order to assay
vessel density, hemisected placentas were stained with IB4 as above.
Sixtotwelvephotographsat20Xmagnificationweretakenfromtwo
different sections (middle region) representing more than 90% of the
labyrinth. Thevesselswerecounted using NIH ImageJ softwarethat
equally distributes 208 crosses (comprising a .96 mm
2 grid) over the
photograph. A blinded observer counted the vessels touching each
cross. Comparisons between groups were performed using the two-
tailed unpaired Student’s t-test (Excel, Microsoft).
Endothelial Cell Isolation and Analysis of Cre Deletion
Minced E13.5 embryos were digested with collagenase II (2 mg/
ml) and DNase I to generate a single cell suspension. After
centrifuging, the cell pellet was washed, and passed through a
40 um cell strainer. The cells suspension was incubated with Anti-
Pecam (CD31, BD Biosciences) coated Dynabeads (Dynal) per
manufacturer’s recommendations. The beads were separated using
a magnetic particle concentrator. Western analysis for PC2 was
performed and the relative expression was calculated by correcting
forloading andthennormalizingtoPkd2
endo+(100%expression).For
Pkd1, genomic DNA was prepared from endothelial cells and a 3
primer PCR amplification for 25 cycles was performed with SYBR
green Master Mix (Applied Biosystems) using primers and
conditions previously described [15]. Both Pkd1 wild type (WT)
and conditional alleles give a180 bp band while the null or deleted
(KO) allele yields a 250 bp band. The relative intensity of the two
bands was determined using the Molecular Imager SystemH Pharos
FxPlus
TM (Bio-Rad) and used to calculate the relative Pkd1 deletion
(intensity KO band4intensity WT band + KO band).
Supporting Information
Supplementary Methods S1
Found at: doi:10.1371/journal.pone.0012821.s001 (0.05 MB
DOC)
Figure S1 Generation of Floxed and Mutant alleles of Pkd2.A .
Schematic representation of the Pkd2 targeting construct (TC),
Pkd2 locus (Gene) and resulting allelic series. Pkd2
flox11-13
(Pkd2
tm1Tjw1) refers to the floxed allele. Pkd2
Dneo (Pkd2
tm1.1Tjw) results
from deletion of the Neomycin cassette. We refer to this allele as
Pkd2
cond in the body of the paper. Deletion with Cre recombinase
yields the mutant allele, Pkd2
D11-13 (Pkd2
tm1.2Tjw). This is referred to
as Pkd2
2 in the body of the paper. The restriction maps for AflII
and BglII are as indicated. The location of PCR primers a, b, and c
in the various Pkd2 alleles is shown along with the size of the
corresponding PCR products. The red and yellow triangles
represent loxP and Frt sites, respectively and grey ovals correspond
to exons. B. Genomic Southern showing germ line transmission of
Pkd2
flox11-13 allele. The ‘‘+’’ signifies a mouse carrying the targeted
allele and ‘‘-’’ is a wild type littermate. DNA from the offspring of
highly chimeric mice was digested with either AflII (top) or BglII
(bottom) and hybridized with 59 or 39 probes (position depicted in
panel A). In each case the probe detects the wild type band and a
larger band as expected for the appropriately targeted locus.
Internal probes (position depicted in panel A) only hybridize to the
bands recognized by the external probes indicating that there were
no random integration events. C. Genotyping with a 3-primer
PCR strategy. Primers a, b and c were used to identify wild type,
floxed and deleted alleles. A representative ethidium bromide
stained gel is shown. Primers a and b amplify a 232 bp band from
the wild type allele and a 318 bp band in the floxed allele. Primers
a and c are far apart and do not amplify a product from genomic
DNA in either allele. In the deleted allele the primer b site is lost
and a 143 bp band is amplified from primers a and c. D. The
Pkd2
D11-13 mutant allele is transcribed. The intron/exon structure
of wild type and mutant (Pkd2
D11-13) alleles along with the location
of primers f, h, i are shown schematically. Cre recombinase is
predicted to result in a frame shift and stop codon ‘‘UAG’’ in exon
14. RTPCR products amplified from embryos of the indicated
genotypes are shown. ‘‘-’’ is the water control. Primers f and i yield
a 900 bp and a 496 bp product from wild type and and mutant
alleles respectively. Both bands are seen in a heterozygote,
Pkd2
Neo3/D11-13. The faint band indicated by the asterisk is likely
due to heteroduplex formation. Primers h and i, contained within
exon 15, amplifya 105 bpband from both alleles.E.ThePkd2
D11-13
mutant allele does not yield protein. Total lysates derived from
embryos of the indicated genotypes were used to prepare Western
blots. Both the N-terminal and C-terminal PC-2 antibodies fail to
detect polycystsin-2 in the Pkd2
D11-13 mutant. Alpha tubulin was
used as a loading control. F. Cell lysates were prepared from various
embryos and humanPKD2 transfected HEKcells (positive control).
PC-2 was immunoprecipitated and then detected with either N-
terminal or C-terminal antibodies as indicated. PC-2 cannot be
immunoprecipitated from Pkd2
D11-13 homozygotes with either the
N-terminal or C-terminal antibody. The star indicates a non-
specific band that is seen when the N-terminal antibody is used for
both IP and Western blot. This non-specific band was not visualized
when total lysates were probed with the N-terminal antibody (data
not shown).
Found at: doi:10.1371/journal.pone.0012821.s002 (3.61 MB TIF)
Figure S2 Phenotypes of Floxed and Mutant alleles of Pkd2.A .
Pkd2
D11-13/+ heterozygotes were bred and pregnancies harvested
at various time points as indicated. The gross phenotypes of
Pkd1 and Pkd2 in Placenta
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D11-13/D11-13 embryos are demonstrated. The asterisk, ‘‘*’’,
indicates edema, Arrowheads denote areas of hemorrhage. The
E16.5 embryos were dead and in the process of being resorbed. B.
Hematoxylin and eosin staining of kidney and pancreas sections of
normal (top) and mutant (bottom) E15.5 embryos. C. Pkd2
cond/D11-
13; Meox2-Cre
+ mice were generated using standard breeding
protcols. The top left panel shows the general appearance of a P0
Pkd2
cond/D11-13; Meox2-Cre
+ neonate with edema (asterisk). On the
right, necropsy shows a cystic kidney. In the bottom panels,
histopathology confirms the presence of cysts in the kidney (K) and
pancreas (P). ‘‘Cy’’ indicates cysts. D. The top left panel shows the
general appearance of another P0 Pkd2
cond/D11-13; Meox2-Cre
+
neonate. Necropsy of the pup, which died shortly after birth,
demonstrates situs inversus (top middle and right panels). The
areas in the red squares are magnified in the lower panels. Right-
sided stomach and spleen (left lower panel) as well as dextrocardia
(right lower panel, arrow) are seen. L: liver, P: pancreas, K: kidney,
S: stomach, Sp: spleen, Cy: cyst. E. Cysts derive from all tubular
segments. Cystic kidneys from the embryo in panel A stained with
markers for proximal tubule (LTL, green), thick ascending limb
(Tamm Horsfall, red) collecting duct (aquaporin-2, red) and Nuclei
(DAPI, blue). F. Gross appearance of an E14.5 Pkd2
endo2 embryo
and littermate control. The Pkd2
endo2 embryo has polyhydramnios
indicated by the asterisk. At the right, the yolk sac was removed
and neither embryo has edema. G. Haematoxylin-eosin staining of
kidney and heart from an E13.5 Pkd2
endo2 embryo and littermate
control. As in Pkd1
endo2, embryos, there were no obvious
histopathology abnormalities in the animals bearing the Tie-2
Cre recombinase (Pkd2
endo2).
Found at: doi:10.1371/journal.pone.0012821.s003 (9.42 MB TIF)
Table S1 Genotypes resulting from Pkd1
+/2 Intercrosses.
Found at: doi:10.1371/journal.pone.0012821.s004 (0.11 MB
PDF)
Table S2 Genotypes resulting from mating of Pkd2 allele.
Found at: doi:10.1371/journal.pone.0012821.s005 (0.15 MB
PDF)
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